Search

everythinglearnresearchcommunity

for

Search:↓

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

CTE can distort results in hair growth trials, so exclude it carefully.

Hair loss in women linked to higher sexual dysfunction risk.

No significant difference in iron deficiency between women with or without hair loss.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Some breast cancer chemotherapy can cause permanent hair loss.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.